Outcome of the Board Meeting held on Friday 14th November, 2025 and submission of Un-Audited Financial Results (Standalone & Consolidated) for the Second Quarter and half years ended on ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board approved unaudited financial results for Q2 and H1 FY26 (ended September 30, 2025). On a standalone basis, revenue from operations rose to Rs. 667.96 lakhs in Q2 (vs Rs. 639.58 lakhs YoY) and Rs. 1,795.19 lakhs for H1 (vs Rs. 1,287.42 lakhs YoY, up about 39%). Profit after tax more than doubled to Rs. 53.48 lakhs in Q2 (vs Rs. 25.03 lakhs) and rose to Rs. 111.96 lakhs for H1 (vs Rs. 50.33 lakhs, up roughly 122%). On a consolidated basis (which includes subsidiary Padmavati Chemicals), H1 revenue nearly doubled to Rs. 2,540.77 lakhs and H1 PAT jumped to Rs. 118.27 lakhs from Rs. 50.33 lakhs a year ago. EPS stood at Rs. 0.77 (Q2 standalone) and Rs. 1.61 (H1 standalone). The statutory auditor M/s. S N D K & Associates LLP issued an unmodified limited review report with no qualifications. The company also highlighted that its name change to Ecofinity Atomix Limited is subject to BSE approval.
Strong YoY growth in both revenue and profitability, especially at the consolidated level, signals improving business momentum. Positive operating cash flow and a clean auditor review are supportive, though investors should note the small absolute size of the business and the pending name-change approval.